RJS posted this yesterday. It's worth reposting:
Post# of 36537
"I lost myself on my overall point, but I think we are worrying too much on a small capital raise because it’s not like a little food to get a donkey to move a few feet. Get to 27 states mso and pharmacy wise to build a multihundreds of millions in revenue company going until an uplist happens, and at that point who gives a jackass of only about $2 mil with a 30% discount on anything? Joe and his insiders already personally gauranteed more than that themselves in their personal shares. "
I agree with RJS, build the MSO first. Veneto is the main thing that gives Generex credibility. This whole turnaround is not possible without the Veneto acquisition. I am relieved that Generex has 51% ownership.
The recent slide in the stock and the history of GNBT remind us too painfully the struggle to keep GNBT above $1-$2.
With strong revenues in the hundreds of millions, what's $2-3 million toxic financing. Generex can pay it off in a heartbeat. Well, should be able to.